BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 36980267)

  • 1. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
    Nin DS; Deng LW
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
    Yang P; Meng M; Zhou Q
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
    Gordeeva O
    Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
    Yang P; Huo Z; Liao H; Zhou Q
    Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer/testis antigens: from serology to mRNA cancer vaccine.
    Fan C; Qu H; Wang X; Sobhani N; Wang L; Liu S; Xiong W; Zeng Z; Li Y
    Semin Cancer Biol; 2021 Nov; 76():218-231. PubMed ID: 33910064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.
    Kim R; Kulkarni P; Hannenhalli S
    BMC Cancer; 2013 Mar; 13():144. PubMed ID: 23522060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
    Bodey B
    Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy.
    Shim K; Jo H; Jeoung D
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer/Testis Antigens into mitochondria: a hub between spermatogenesis, tumorigenesis and mitochondrial physiology adaptation.
    Aurrière J; Goudenège D; Baris OR; Boguenet M; May-Panloup P; Lenaers G; Khiati S
    Mitochondrion; 2021 Jan; 56():73-81. PubMed ID: 33220498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-testis antigens in canine histiocytic sarcoma and other malignancies.
    Nemec PS; Kapatos A; Holmes JC; Stowe DM; Hess PR
    Vet Comp Oncol; 2019 Sep; 17(3):317-328. PubMed ID: 30854786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Cancer-Testis Antigens in Pediatric Cancers.
    Ghafouri-Fard S
    Asian Pac J Cancer Prev; 2015; 16(13):5149-52. PubMed ID: 26225644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.
    Hikmet F; Rassy M; Backman M; Méar L; Mattsson JSM; Djureinovic D; Botling J; Brunnström H; Micke P; Lindskog C
    Mol Oncol; 2023 Dec; 17(12):2603-2617. PubMed ID: 37341056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation Profile of Cancer Testis Antigens in Colorectal Cancer.
    Abu N; Rus Bakarurraini NAA; Nasir SN; Ishak M; Baharuddin R; Jamal R; Ab Mutalib NS
    Iran J Immunol; 2023 Mar; 20(1):83-91. PubMed ID: 36932973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SSX family of cancer-testis antigens as target proteins for tumor therapy.
    Smith HA; McNeel DG
    Clin Dev Immunol; 2010; 2010():150591. PubMed ID: 20981248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer.
    Yang P; Qiao Y; Meng M; Zhou Q
    Front Oncol; 2022; 12():864159. PubMed ID: 35574342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of cancer/testis antigens (CTAs) in breast cancer.
    Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
    Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential immune-eliciting cancer testis antigens in colorectal cancer.
    Chi Soh JE; Abu N; Jamal R
    Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice.
    Lam RA; Tien TZ; Joseph CR; Lim JX; Thike AA; Iqbal J; Tan PH; Yeong JPS
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.